NYSE
Organon & Co. (OGN)
♥ 598 Thanks from members
Organon & Co. (OGN) exhibits strong bullish sentiment driven by an all-cash takeover offer from Sun Pharma near $14.00 per share, though analysts warn of substantial debt, potential regulatory hurdles, and single-digit downside risk if the deal collapses.